Product Description
Recombinant SARS-CoV-2 Spike S2 ECD Protein is produced by Baculovirus-Infected Cells expression system. The target protein is expressed with sequence (Ser686-Pro1213) of SARS-CoV-2 Spike S2 ECD (Accession #YP_009724390.1) fused with a His-tag at the C-terminus.
Usage Statement
Research use only, not for direct human use.
Key Applications
ELISA, SPR, SDS-PAGE, Western Blotting, Immunoprecipitation, Immune Blocking, and Binding Assay
Specifications
SKU | 08L100007 |
Alternate Names | S2 protein; Spike glycoprotein Subunit2; S glycoprotein Subunit2; Spike protein S2 |
Concentration | 1 mg/mL if dissolve in 100 µL of ddH20 or biological buffer |
Conjugate | Unconjugated |
Electroendosmosis | < 0.1 EU/μg of the protein by LAL method |
Grade | Molecular Grade |
Host | Baculoviral-Infected Sf9 cells |
Pack Size | 100 μg |
Preparation Method | Affinity Chromatography |
Protein Tag | C-His |
Purity | > 97% by SDS-PAGE |
Solubility | Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Addition of a carrier protein (such as 0.05-0.1% BSA) is recommended for long-term storage. |
Species Reactivity | Human, Mouse, Rat |
Storage | -20° |
Usage Statement | Research use only, not for direct human use. |
Documents
Certificate of Analysis (COA)
Datasheet
Datasheet
English (United States)
Safety Data Sheets
English (United States)
Brochures
Brochures
English (United States)